David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs
Update: 2025-12-16
Description
Visit https://www.peervoice.com/HPJ860 to view the entire programme with slides. After completing “David Cherney, MD, PhD / Abhinav Sharma, MD, PhD - Optimizing Cardio-Kidney Protection in Patients With T2D and CKD: Expert Insights on the Evolving Role of GLP-1 RAs”, participants will be able to: Examine the pathogenic mechanisms underlying chronic kidney disease (CKD) and type 2 diabetes (T2D), and their relevance to the foundational pillars of cardio-kidney protection; Discuss the latest clinical evidence on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in providing cardio-kidney protection for patients with CKD and T2D; and Identify strategies to optimize cardio-kidney outcomes in patients with CKD and T2D.
Comments
In Channel



